Zhejiang Chemsyn Pharm Co (BJSE:920656) Total Receivables: ¥51.2 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920656 Zhejiang Chemsyn Pharm Co Ltd BJSE:920656
36 GF Score
Price ¥13.04
! 4 Warning Signs
View Full Analysis

What is Zhejiang Chemsyn Pharm Co Total Receivables?

Zhejiang Chemsyn Pharm Co BJSE:920656 36 Total Receivables is ¥51.2 Mil as of Mar. 2026. GuruFocus rates BJSE:920656 with a GF Score™ of 36/100. The stock has 4 warning signs investors should review.

Zhejiang Chemsyn Pharm Co's Total Receivables for the quarter that ended in Mar. 2026 was ¥51.2 Mil.

Zhejiang Chemsyn Pharm Co Total Receivables Related Terms

Zhejiang Chemsyn Pharm Co Total Receivables Historical Data

* Premium members only.

The historical data trend for Zhejiang Chemsyn Pharm Co's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Chemsyn Pharm Co Total Receivables Chart

Zhejiang Chemsyn Pharm Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.77 27.92 41.88 28.00 32.07

Zhejiang Chemsyn Pharm Co Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.82 44.40 41.66 32.07 51.23
BJSE:920656
36GF Score
Zhejiang Chemsyn Pharm Co Ltd BJSE:920656
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Chemsyn Pharm Co Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of ¥51.2 Mil mean?
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a Total Receivables of ¥51.2 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Zhejiang Chemsyn Pharm Co and its competitors.
Is Zhejiang Chemsyn Pharm Co's Total Receivables too high?
Zhejiang Chemsyn Pharm Co's current Total Receivables is ¥51.2 Mil. Overall, Zhejiang Chemsyn Pharm Co has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Chemsyn Pharm Co's Total Receivables compare to UNH and CVS?
Zhejiang Chemsyn Pharm Co's Total Receivables of ¥51.2 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Healthcare Plans company?
A good Total Receivables depends on the Healthcare Plans industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Zhejiang Chemsyn Pharm Co and its competitors. Zhejiang Chemsyn Pharm Co's current Total Receivables is ¥51.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Chemsyn Pharm Co stock overvalued right now?
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a current Total Receivables of ¥51.2 Mil. The current Total Receivables is ¥51.2 Mil. Zhejiang Chemsyn Pharm Co's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Zhejiang Chemsyn Pharm Co (BJSE:920656), the current Total Receivables is ¥51.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zhejiang Chemsyn Pharm Co Business Description

Address Huayang Road, No. 36, High-tech Industrial Park, Zhejiang Province, Quzhou, CHN
Zhejiang Chemsyn Pharm Co Ltd is engaged in Research, development, production and sales of veterinary drug raw materials, pharmaceutical raw materials and intermediates.
36GF Score

Get the complete analysis for BJSE:920656

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥13.04
Price